The stock's fall snapped a two-day winning streak.

Danaher anticipates a strong 2026 due to its diagnostic portfolio being in highly attractive areas such as molecular testing, ...

Mar Vista Investment Partners, LLC, an investment management company, released its “Mar Vista U.S. Quality Strategy” ...

Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on the Company's fourth quarter 2025 performance in a ...

Shares of Danaher Corp. DHR rose 1.01% to $237.95 Wednesday, on what proved to be an all-around rough trading session for the ...

Meridian Funds, managed by ArrowMark Partners, released its “Meridian Hedged Equity Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The direction of interest ...

Washington, the District Of Columbia-based Danaher Corporation (DHR) designs, manufactures, and markets professional, medical ...

(RTTNews) - Danaher Corp. (DHR) reported a profit for its third quarter that increased from last year and beat the Street estimates. The company's bottom line came in at $1.55 billion, or $2.10 per ...

Danaher Corp (NYSE:DHR) on Tuesday reported first-quarter 2025 sales of $5.74 billion, down 1% year-over-year, beating the consensus of $5.59 billion. Non-GAAP core revenue was flat compared to the ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

Danaher (NYSE: DHR) and Thermo Fisher Scientific (NYSE: TMO) both reported Q3 2025 earnings showing revenue growth around 5%, ...

Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair ...